Japanese pharmaceutical giant Takeda has agreed to buy US drugmaker Ariad Pharmaceuticals for $5.2bn (£4.3bn). Ariad specialises in making medicines for patients with rare forms of leukemia and other rare cancers. The takeover was approved by the boards …
( read original story …)